Mo Bidair
Papers
4
Total Citations
100
H-Index
3
About
Dr. Mo Bidair is a leading urologic surgeon and researcher whose work has fundamentally reshaped the surgical management of benign prostatic hyperplasia (BPH), particularly for patients with large-volume prostates. His primary research focus is the development and validation of Aquablation therapy, a minimally invasive, robotically executed waterjet ablation technique. Dr. Bidair’s landmark contributions include serving as the principal investigator for the pivotal WATER and WATER II clinical trials. His most cited work, the 5-year results of the WATER II trial (49 citations), demonstrated that Aquablation provides durable, safe, and effective relief from lower urinary tract symptoms in men with prostates ranging from 80 to 150 mL—a population historically limited to more invasive open surgery. He further showed that this technology offers a superior sexual function preservation profile compared to traditional transurethral resection of the prostate (TURP). By providing robust, long-term evidence for a novel, less invasive alternative, Dr. Bidair’s research has directly expanded treatment options for a challenging patient demographic, establishing him as a key innovator in the evolution of BPH surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4